Amy DeZern, MD, MHS, on the RACE Trial, Treatment Strategies for Acquired Aplastic Anemia

By Blood Cancer Talks - Last Updated: August 1, 2023

In this episode of “Blood Cancer Talks,” the hosts discuss how to manage acquired aplastic anemia with Dr. DeZern, of the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University School of Medicine.

Dr. DeZern discusses a single-arm study of eltrombopag plus standard immunosuppressive therapy in aplastic anemia, the RACE trial of standard immunosuppressive therapy plus or minus eltrombopag, clinical, and molecular determinants of clonal evolution in patients with aplastic anemia.

Advertisement
Advertisement
Advertisement
Editorial Board